Biology Reference
In-Depth Information
[3] Court M, Selevsek N, Matondo M, et al. Toward a standardized urine proteome analysis
methodology. Proteomics 2011;11:1160-71.
[4] Rai AJ, Gelfand CA, Haywood BC, et al. HUPO Plasma Proteome Project specimen col-
lection and handling: towards the standardization of parameters for plasma proteome
samples. Proteomics 2005;5:3262-77.
[5] Anderson NL, Anderson NG. The human plasma proteome: history, character, and diag-
nostic prospects. Mol Cell Proteomics 2002;1:845-67.
[6] Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD. Character-
ization of the low molecular weight human serum proteome. Mol Cell Proteomics
2003;2:1096-103.
[7] Gundry RL, Fu Q, Jelinek CA, Van Eyk JE, Cotter RJ. Investigation of an albumin-enriched
fraction of human serum and its albuminome. Proteomics Clin Appl 2007;1:73-88.
[8] Thongboonkerd V. Recent progress in urinary proteomics. Proteomics Clin Appl
2007;1:780-91.
[9] Schaub S, Rush D, Wilkins J, et al. Proteomic-based detection of urine proteins associ-
ated with acute renal allograft rejection. J Am Soc Nephrol 2004;15:219-27.
[10] Mann M, Jensen ON. Proteomic analysis of post-translational modifications. Nat Bio-
technol 2003;21:255-61.
[11] Wild D, editor. The Immunoassay Handbook. 3rd ed Oxford: Elsevier; 2005.
[12] Paczesny S, Krijanovski OI, Braun TM, et al. A biomarker panel for acute graft-versus-
host disease. Blood 2009;113:273-8.
[13] Schweitzer B, Roberts S, Grimwade B, et al. Multiplexed protein profiling on microarrays
by rolling-circle amplification. Nat Biotechnol 2002;20:359-65.
[14] Boja E, Hiltke T, Rivers R, et al. Evolution of clinical proteomics and its role in medicine.
J Proteome Res 2011;10:66-84.
[15] Rodland KD. Proteomics and cancer diagnosis: the potential of mass spectrometry. Clin
Biochem 2004;37:579-83.
[16] Srinivasan R, Daniels J, Fusaro V, et al. Accurate diagnosis of acute graft-versus-host
disease using serum proteomic pattern analysis. Exp Hematol 2006;34:796-801.
[17] Imanguli MM, Atkinson JC, Harvey KE, et al. Changes in salivary proteome following
allogeneic hematopoietic stem cell transplantation. Exp Hematol 2007;35:184-92.
[18] O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem
1975;250:4007-21.
[19] Marouga R, David S, Hawkins E. The development of the DIGE system: 2D fluorescence
difference gel analysis technology. Anal Bioanal Chem 2005;382:669-78.
[20] Wang H, Clouthier SG, Galchev V, et al. Intact-protein-based high-resolution three-
dimensional quantitative analysis system for proteome profiling of biological fluids. Mol
Cell Proteomics 2005;4:618-25.
[21] Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Activa-
tion of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science
2008;321:1493-5.
[22] Ferrara JL, Harris AC, Greenson JK, et al. Regenerating islet-derived 3-alpha is a bio-
marker of gastrointestinal graft-versus-host disease. Blood 2011;118:6702-8.
[23] Paczesny S, Braun TM, Levine JE, et al. Elafin is a biomarker of graft-versus-host disease
of the skin. Sci Transl Med 2010;2; 13ra12.
[24] Kaiser T, Kamal H, Rank A, et al. Proteomics applied to the clinical follow-up of patients
after allogeneic hematopoietic stem cell transplantation. Blood 2004;104:340-9.
[25] Brewis IA, Brennan P. Proteomics technologies for the global identification and quantifi-
cation of proteins. Adv Protein Chem Struct Biol 2010;80:1-44.
[26] Faca V, Coram M, Phanstiel D, et al. Quantitative analysis of acrylamide labeled serum
proteins by LC-MS/MS. J Proteome Res 2006;5:2009-18.
[27] Hanash SM, Pitteri SJ, Faca VM. Mining the plasma proteome for cancer biomarkers.
Nature 2008;452:571-9.
[28] Elliott MH, Smith DS, Parker CE, Borchers C. Current trends in quantitative proteomics.
J Mass Spectrom 2009;44:1637-60.
[29] Michalski A, Damoc E, Lange O, et al. Ultra high resolution linear ion trap Orbitrap mass
spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide frag-
mentation modes. Mol Cell Proteomics 2012;11; O111.013698.
[30] MacLean B, Eng JK, Beavis RC, McIntosh M. General framework for developing and
evaluating database scoring algorithms using the TANDEM search engine. Bioinformat-
ics 2006;22:2830-2.
[31] Faca V, Pitteri SJ, Newcomb L, et al. Contribution of protein fractionation to depth of
analysis of the serum and plasma proteomes. J Proteome Res 2007;6:3558-65.
[32] Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK. Multiple reaction monitoring
for quantitative biomarker analysis in proteomics and metabolomics. J Chromatogr
B Anal Technol Biomed Life Sci 2009;877:1229-39.
475
Search WWH ::
Custom Search